InsidersTradesSigma
Track the 지씨지놈 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 지씨지놈 has recorded 4 public disclosures. The latest transaction was reported on 3 February 2026 (Sale). Among the most active insiders: 지노베이션1호사모투자. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
지씨지놈 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of genomic and biopharmaceutical solutions.